Australia markets closed

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
11.32+0.71 (+6.69%)
At close: 4:00PM EST

11.17 -0.15 (-1.33%)
Pre-market: 5:44AM EST

Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
16,658,000
16,658,000
16,887,000
18,854,000
22,385,000
Cost of revenue
8,933,000
8,933,000
9,351,000
10,558,000
11,560,000
Gross profit
7,726,000
7,726,000
7,537,000
8,296,000
10,825,000
Operating expenses
Research development
997,000
997,000
1,010,000
1,213,000
1,848,000
Selling general and administrative
3,671,000
3,671,000
3,806,000
4,214,000
4,986,000
Total operating expenses
4,668,000
4,668,000
4,816,000
5,427,000
6,834,000
Operating income or loss
3,058,000
3,058,000
2,721,000
2,869,000
3,991,000
Interest expense
963,000
963,000
881,000
920,000
875,000
Total other income/expenses net
-6,500,000
-6,500,000
-3,108,000
-4,480,000
-21,498,000
Income before tax
-4,406,000
-4,406,000
-1,265,000
-2,596,000
-18,379,000
Income tax expense
-168,000
-168,000
-278,000
-195,000
-1,933,000
Income from continuing operations
-4,100,000
-4,100,000
-1,000,000
-2,472,000
-16,449,000
Net income
-3,990,000
-3,990,000
-999,000
-2,150,000
-16,265,000
Net income available to common shareholders
-3,990,000
-3,990,000
-999,000
-2,399,000
-16,525,000
Basic EPS
-
-
-0.91
-2.35
-16.26
Diluted EPS
-
-
-0.91
-2.35
-16.26
Basic average shares
-
-
1,091,000
1,021,000
1,016,000
Diluted average shares
-
-
1,091,000
1,021,000
1,016,000
EBITDA
-
-1,886,000
1,338,000
166,000
-15,392,000